Loading…
Sahajanand Medical Technologies (SMT)₹492.90−7.82%Medical Equipment & Supplies
In the Jun 2026 quarter (consolidated), Sahajanand Medical Technologies reported sales of ₹352 Cr and net profit of ₹15.04 Cr. For the year to Mar 2026, sales were ₹1,212 Cr and net profit ₹69.25 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Jun 2026 | |
|---|---|
| Sales | 352 |
| Expenses | 303 |
| Operating Profit | 49.03 |
| OPM % | 14.0% |
| Other Income | 3.01 |
| Interest | 6.98 |
| Depreciation | 19.95 |
| Profit before tax | 23.98 |
| Tax % | 37.9% |
| Net Profit | 15.04 |
| EPS (Rs) | 1.45 |
| Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 590 | 690 | 903 | 1,025 | 1,212 |
| Expenses | 538 | 640 | 792 | 895 | 1,038 |
| Operating Profit | 49.01 | 48.04 | 110 | 129 | 171 |
| OPM % | 8.0% | 7.0% | 12.0% | 13.0% | 14.0% |
| Other Income | −38.97 | −19.01 | 7.01 | −4.99 | 7.99 |
| Interest | 19.93 | 21.92 | 18.93 | 20.92 | 23.92 |
| Depreciation | 34.89 | 37.87 | 63.84 | 62.82 | 73.82 |
| Profit before tax | −44.97 | −29.97 | 33.01 | 40.97 | 80.02 |
| Tax % | 59.9% | 60.9% | 122.0% | 37.9% | 13.9% |
| Exceptional items | −23.03 | −3.01 | 0.00 | −4.01 | 0.00 |
| Net Profit | −72.29 | −49.14 | −7.02 | 25.08 | 69.25 |
| EPS (Rs) | −8.16 | −5.27 | −1.27 | 2.02 | 6.46 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 9.03 | 9.03 | 10.03 | 10.04 | 10.03 |
| Reserves | 325 | 393 | 531 | 556 | 686 |
| Borrowings | 326 | 387 | 202 | 255 | 307 |
| Other Liabilities | 192 | 213 | 228 | 275 | 274 |
| Total Liabilities | 851 | 1,002 | 971 | 1,096 | 1,277 |
| Fixed Assets | 203 | 207 | 296 | 288 | 343 |
| CWIP | 60.18 | 122 | 13.05 | 6.02 | 9.03 |
| Investments | 0.00 | 0.00 | 5.98 | 4.98 | 58.78 |
| Other Assets | 588 | 672 | 655 | 797 | 866 |
| Inventories | 143 | 160 | 252 | 267 | 309 |
| Trade receivables | 255 | 236 | 215 | 263 | 286 |
| Cash & equivalents | 145 | 175 | 74.21 | 102 | 75.27 |
| Total Assets | 851 | 1,002 | 971 | 1,096 | 1,277 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from operating activity | 46.18 | 17.05 | — | 41.16 | 74.26 | 105 |
| Cash from investing activity | −169 | −154 | — | −41.97 | −50.01 | −120 |
| Cash from financing activity | 212 | 109 | — | 12.97 | 5.99 | −11.97 |
| Net cash flow | 88.98 | −28.97 | — | 11.99 | 28.98 | −25.99 |
| Capex | 30.87 | 94.60 | 23.91 | 41.86 | 48.79 | 97.59 |
| Free cash flow | 17.97 | −75.86 | — | 1.99 | 25.95 | 16.97 |
| CFO / OP % | 116.0% | 86.0% | — | 55.0% | 85.0% | 79.0% |
| Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 158 | 125 | 87 | 94 | 86 |
| Inventory days | 329 | 330 | 397 | 389 | 384 |
| Days payable | 252 | 213 | 129 | 152 | 137 |
| Cash conversion cycle | 234 | 241 | 354 | 330 | 332 |
| Working capital days | 122 | −9 | 69 | 56 | 63 |
| ROCE % | — | 1.0% | — | 10.1% | 11.1% |
For the Jun 2026 quarter, Sahajanand Medical Technologies reported sales of ₹352 Cr and net profit of ₹15.04 Cr. The operating margin was 14.0%.
Sahajanand Medical Technologies' sales for the year to Mar 2026 were ₹1,212 Cr.
Net profit for the year to Mar 2026 was ₹69.25 Cr. Earnings per share over the same trailing period were ₹6.46.
Sahajanand Medical Technologies reported borrowings of ₹307 Cr at Mar 2026, against cash and equivalents of ₹75.27 Cr.
Cash from operations was ₹105 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹16.97 Cr.